SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Predictive Oncology Inc. (AGPU) (CIK 0001446159) (AGPU) — Dec 17, 2019

Predictive Oncology Inc. (AGPU) (CIK 0001446159)
Date: Dec. 17, 2019 · CIK: 0001446159 · Accession: 0001171843-19-008175

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-235441

Date
December 17, 2019
Author
Not clearly detected
Form
CORRESP
Company
Predictive Oncology Inc. (AGPU) (CIK 0001446159)

Letter

Re: Predictive Oncology Inc.

December 17, 2019

BY EDGAR

United States Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attention: Irene Paik

Registration Statement on Form S-3

File No. 333-235441

Request for Acceleration

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Predictive Oncology Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”), be accelerated so that it will be declared effective at 3:00 p.m. Eastern Standard Time on December 20, 2019, or as soon thereafter as practicable.

Very truly yours,
Predictive Oncology Inc.

Show Raw Text
CORRESP
1
filename1.htm

December 17, 2019

BY EDGAR

United States Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attention: Irene Paik

Re:         Predictive Oncology Inc.

Registration Statement on Form S-3

File No. 333-235441

Request for Acceleration

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations
under the Securities Act of 1933, as amended, Predictive Oncology Inc., a Delaware corporation (the “Registrant”),
hereby requests that the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”),
be accelerated so that it will be declared effective at 3:00 p.m. Eastern Standard Time on December 20, 2019, or as soon thereafter
as practicable.

    Very truly yours,

    Predictive Oncology Inc.

    By:
    /s/ Bob Myers

    Name: Bob Myers

    Title: Chief Financial Officer